In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RiboTargets Ltd.

Division of Ligand Pharmaceuticals Inc.
www.ribotargets.com

Latest From RiboTargets Ltd.

European Notebook: AstraZeneca Snuggles Up To Potential Partners In New Cambridge HQ, Viagra Patents Expire In Europe

AstraZeneca's new HQ is to cornerstone a growing U.K. cluster of clinical and research assets; the EU and U.S. start talks on what could be the world's largest free trade agreement; Viagra patent expiry provides a lift for European generic companies; European wholesalers support the liquidity of European health care markets; new pricing system for generics in Ireland.

BioPharmaceutical Europe

Intra-Biotech Consolidation in Europe? Not Affordable.

Bankers and consultants have long been urging the virtues of consolidation onto a financially strapped biotech industry. But few companies on either side of the Atlantic have been listening.
BioPharmaceutical Europe

New Look for British Biotech

British Biotech's proposed merger with RiboTargets nets the company an entirely new discovery engine, but is only a first, small step in the downtrodden firm's transformation.
BioPharmaceutical Europe

M&A Makes Sense for Procognia

Procognia's acquisition of fellow Apax portfolio company Sense Proteomic could indicate a more proactive stance from VCs intent on consolidating their bets behind likely winners.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ligand Pharmaceuticals Inc.
  • Senior Management
  • Simon J Sturge, CEO
    David Knowles, CSO
    Susan Lowther, Dir., Fin.
    Harry Finch, Dir., Research
    Nigel Clark, Mgr., Bus. Dev.
  • Contact Info
  • RiboTargets Ltd.
    Phone: (44) 1223 895555
    Granta Park
    Abington, CB1 6GB
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register